Evidence map›Paper›PMID 34676040›Full record

ArticleACS medicinal chemistry letters2021

Intramolecular Ring-Opening Decomposition of Aryl Azetidines.

Guoyun Bai, Thomas N O'Connell, Michael A Brodney, Christopher R Butler, Lara C Czabaniuk, Adam M Gilbert, Erik A LaChapelle, Chao Li, Laura A McAllister, Kevin Ogilvie and 8 more

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Guoyun BaiDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Thomas N O'ConnellDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Michael A BrodneyMedicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States.ORCID https://orcid.org/0000-0001-7592-4097
Christopher R ButlerMedicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States.ORCID https://orcid.org/0000-0002-9387-5011
Lara C CzabaniukDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Adam M GilbertDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.ORCID https://orcid.org/0000-0002-2300-8836
Erik A LaChapelleMedicine Design, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Chao LiDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Laura A McAllisterMedicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States.ORCID https://orcid.org/0000-0001-7406-2843
Kevin OgilvieMedicine Design, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Laurence PhilippeDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Romelia Salomon-FerrerLa Jolla Laboratories, Pfizer Worldwide Research and Development, La Jolla, California 92121, United States.
Michael J ShapiroDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Jeremy T StarrDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Daniel P UccelloDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Jane M WithkaDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Jiangli YanDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Matthew F BrownDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.ORCID https://orcid.org/0000-0003-2496-9089
Pfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ring strain present in azetidines can lead to undesired stability issues. Herein, we described a series of N-substituted azetidines which undergo an acid-mediated intramolecular ring-opening decomposition via nucleophilic attack of a pendant amide group. Studies were conducted to understand the decomposition mechanism enabling the design of stable analogues.

Identifiers

PMID34676040
PMCPMC8521649
OpenAlexW3202275658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.